Yes, we’ve undersold the vaccine. Marketing can fix that
Marketing can improve on current public-health messaging, which undersells the shot and sows confusion.
Most recent articles by Marc Iskowitz
Klick Health elevates Schaefer and Rice to co-president and launches intel unit
Ari Schaefer and Greg Rice were formally announced at an internal town hall meeting in December.
‘Don’t clap. Just don’t make me treat you.’ McCann study reveals comparative shift in doctors’ emotional state
Data on physicians’ emotional state pre- versus post-pandemic reaffirm the need for ‘doctorness,’ but come with some baggage for the profession.
As agencies drag their feet on diversity, some Black creatives take matters into their own hands
Excessive ‘keyboard advocacy’ spurs Black execs to hold white leaders to goals, agitate for greater commitment.
Pfizer CEO on battling virus, tackling new variants and eventual vindication
Albert Bourla shared why he has yet to receive his company’s coronavirus vaccine and more in a virtual appearance Thursday.
As docs grow irritated with their digital outreach, pharmas see imperative to fix pain points
Could this finally be the ‘dawning of experience’ in life sciences?
How pharma brands handled paid social during Trump’s final 2 weeks in office
Some brands that paused Twitter ads after the Capitol riot have yet to return.
W2O plucks a rival’s digital chief, two other tech vets
Saitta, Mickelberg and Mendell further bolster the agency’s health-tech business.
Until we meet again: Reflections from a JPMorgan Health Conference like no other
There were pluses and minuses to attending from afar.
